constructed a humanized CAR33VH CAR, comprised of a human heavy-chain variable fragment, that exhibited antitumor activity to CD33 high expressed MOLM14 and HL60 cell lines and eliminated tumors in a MOLT-14 AML mouse model (131). The gene discussed is CD33; the disease is acute myeloid leukemia.